Digital Look

Welcome to Digital Look++,
you are not logged in

Glaxosmithkline Plc (GSK)

$ 33.70

FDA Approves Promacta(R) (Eltrombopag), the Firs...	20-Nov-2008	PR Newswire
Study Found That Long Term Use of Advair Diskus(...	29-Oct-2008	PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies...	29-Oct-2008	PR Newswire
New Research Shows Many Patients with Persistent...	28-Oct-2008	PR Newswire
GlaxoSmithKline to Acquire the Leading Dry Mouth...	21-Oct-2008	PR Newswire
GSK Notice of Third Quarter 2008 Results Announc...	20-Oct-2008	PR Newswire
LF Elimination Program Treats Over Half Billion ...	07-Oct-2008	PR Newswire
alli(TM) Partners with Breast Cancer Network of ...	22-Sep-2008	PR Newswire
MultiVu Video Feed: NEW BRAIN IMAGING SHOWS THE ...	18-Sep-2008	PR Newswire
GSK and XenoPort Announce Submission of New Drug...	16-Sep-2008	PR Newswire
A New Interactive Consumer Experience Highlighti...	28-Sep-2007	PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ...	28-Sep-2007	PR Newswire
GSK Receives Decision From FDA on Advair(R) 500/...	08-Aug-2007	PR Newswire
GlaxoSmithKline Receives New HHS Order for H5N1 ...	03-Aug-2007	PR Newswire
FDA Issues Second Approvable Letter for Trexima(...	02-Aug-2007	PR Newswire
GlaxoSmithKline Presents Avandia Data To FDA	30-Jul-2007	PR Newswire
FDA Advisory Panel Votes 22 to 1 for Avandia(R) ...	30-Jul-2007	PR Newswire
ChemoCentryx Achieves $5 Million Milestone from ...	24-Jul-2007	PR Newswire
GSK's Cervical Cancer Candidate Vaccine Cervarix...	18-Jul-2007	PR Newswire
Pharmacopeia Advances First Therapeutic Program ...	17-Jul-2007	PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

CEO	Emma Walmsley